Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2023-08-23 Earnings Release
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
First half results 2023 for Medistim ASA
Earnings Release Classification · 90% confidence The document text explicitly mentions 'First half results 2023' and invites participants to a 'webinar' presentation of these results, providing a registration link. This structure—announcing the release of periodic financial results and inviting stakeholders to a presentation/call—is characteristic of an Earnings Release (ER) or, more specifically, an announcement leading up to the discussion of those results. Since the text is very short (619 chars) and focuses on the *invitation* to the presentation of the results rather than the detailed financial figures themselves, it strongly suggests an announcement about the upcoming results presentation. However, the core content is the 'First half results 2023'. If the full results document were attached, it would be RPA/RNS. Since this is an announcement about the results presentation, it aligns best with an Earnings Release (ER) which typically precedes or accompanies the detailed report, or potentially a Call Transcript (CT) if the text was the transcript itself, but here it is an invitation. Given the focus on 'First half results', ER is the most appropriate fit for the underlying financial event being announced, even if it's an invitation to the call discussing those results. If the document were longer and contained the actual financial highlights, ER would be certain. As a short announcement about the results presentation, ER is the best fit among the financial reporting codes. H1 2023
2023-08-23 English
Medistim Announces Partnership with Groundbreaking Cardiac Surgery Trial Exclusively Dedicated to Women
Regulatory Filings Classification · 100% confidence The document is a press release announcing a new partnership between Medistim ASA and the ROMA-Women cardiac surgery trial. It details the purpose of the trial, the involvement of Medistim's technology, and includes quotes from the CEO and a principal investigator. This type of announcement, which is not a formal regulatory filing (like 10-K, IR, or ER) but rather a general corporate update about business development or strategic alignment, fits best under the 'Regulatory Filings' (RNS) category as a general corporate announcement, or potentially 'LTR' if it were related to legal/regulatory action, but here it is clearly a business partnership announcement. Since there is no specific category for 'Partnership Announcement' and it is not a financial report, dividend notice, or management change, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback classification.
2023-06-05 English
Notification of trade
Director's Dealing Classification · 100% confidence The document is titled "Notification of trade" and explicitly details a transaction involving the President and CEO (Kari E. Krogstad) selling shares to another major shareholder. This directly corresponds to the definition of Director's Dealing (insider trades by executives). The filing type code for this is DIRS.
2023-05-02 English
Ex dividend NOK 4.50 today
Notice of Dividend Amount Classification · 98% confidence The document text is extremely short (148 characters) and announces a specific financial event: an ex-dividend date and amount (NOK 4.50). This directly relates to the distribution of profits to shareholders. The most specific category for announcing dividend amounts and payment details is 'Notice of Dividend Amount' (DIV). It is not a full report, a management change, or a general regulatory filing.
2023-04-25 English
FIRST QUARTER FINANCIAL RESULTS 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report for the first quarter 2023' for Medistim ASA. It contains detailed financial statements (Profit and Loss, Balance Sheet), business segment updates, and performance analysis for the specified quarter. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-04-25 English
FIRST QUARTER FINANCIAL RESULTS 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT' and 'FIRST QUARTER FINANCIAL RESULTS 2023'. It contains detailed financial statements, including sales revenue, operating profit (EBIT), balance sheet data, and geographic sales splits, prepared in accordance with IFRS and IAS 34. It is a comprehensive quarterly financial report, not an announcement or a summary, and thus fits the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-04-25 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.